584 related articles for article (PubMed ID: 31444335)
1. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy.
Yong T; Zhang X; Bie N; Zhang H; Zhang X; Li F; Hakeem A; Hu J; Gan L; Santos HA; Yang X
Nat Commun; 2019 Aug; 10(1):3838. PubMed ID: 31444335
[TBL] [Abstract][Full Text] [Related]
2. Domino-Like Intercellular Delivery of Undecylenic Acid-Conjugated Porous Silicon Nanoparticles for Deep Tumor Penetration.
Yong T; Hu J; Zhang X; Li F; Yang H; Gan L; Yang X
ACS Appl Mater Interfaces; 2016 Oct; 8(41):27611-27621. PubMed ID: 27653799
[TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
4. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
[TBL] [Abstract][Full Text] [Related]
5. Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3'-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer.
Sarkar R; Biswas S; Ghosh R; Samanta P; Pakhira S; Mondal M; Dutta Gupta Y; Bhandary S; Saha P; Bhowmik A; Hajra S
J Nanobiotechnology; 2024 May; 22(1):285. PubMed ID: 38796426
[TBL] [Abstract][Full Text] [Related]
6. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
[TBL] [Abstract][Full Text] [Related]
7. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer.
Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J
Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501
[TBL] [Abstract][Full Text] [Related]
8. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy.
Xue Y; Bai H; Peng B; Tieu T; Jiang J; Hao S; Li P; Richardson M; Baell J; Thissen H; Cifuentes A; Li L; Voelcker NH
Adv Healthc Mater; 2022 Jun; 11(12):e2200076. PubMed ID: 35306736
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
10. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
11. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
[TBL] [Abstract][Full Text] [Related]
13. Influence of the method of preparation on the characteristics and performance of cholesterol-based polymeric nanoparticles for redox-triggered release of doxorubicin in tumor cells.
Gonzalez-Fajardo L; Ndaya D; Kasi RM; Lu X
Int J Pharm; 2019 Nov; 571():118701. PubMed ID: 31593806
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
[TBL] [Abstract][Full Text] [Related]
15. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
16. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
[TBL] [Abstract][Full Text] [Related]
18. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
19. Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery.
Newham G; Mathew RK; Wurdak H; Evans SD; Ong ZY
J Colloid Interface Sci; 2021 Feb; 584():669-683. PubMed ID: 33223243
[TBL] [Abstract][Full Text] [Related]
20. Iron-silicate-coated porous silicon nanoparticles for in situ ROS self-generation.
Um H; Kang RH; Kim D
Colloids Surf B Biointerfaces; 2023 May; 225():113273. PubMed ID: 36965332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
